About the Childhood Rhabdomyosarcoma Session
Childhood rhabdomyosarcoma is a rare type of cancer that forms in the soft tissues of children, commonly in muscles attached to bones. Despite its rarity, it's one of the most common soft tissue sarcomas in children. Research in this area focuses on understanding the genetic mutations driving its development and identifying more effective treatment strategies. Recent advancements in cancer research have led to targeted therapies that aim to inhibit specific molecular pathways involved in tumor growth. Additionally, immunotherapy approaches, harnessing the body's immune system to target cancer cells, show promise in treating childhood rhabdomyosarcoma. Collaborative efforts among researchers worldwide continue to push the boundaries in improving outcomes for children battling this aggressive cancer.
Topics Covered in Childhood Rhabdomyosarcoma
Embryonal Subtype
Alveolar Subtype
PAX Fusion Status
Risk Stratification
Multiagent Chemotherapy
Surgery & Radiotherapy
Related Scientific Sessions at CIOC 2027
Why Attend the Childhood Rhabdomyosarcoma Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Childhood Rhabdomyosarcoma work, reviewed by the scientific committee.
Network Globally
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Childhood Rhabdomyosarcoma research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join CIOC 2027 for the Childhood Rhabdomyosarcoma track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Childhood Rhabdomyosarcoma Conference 2027 — FAQs
What is the Childhood Rhabdomyosarcoma track at CIOC 2027?
The Childhood Rhabdomyosarcoma track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Childhood Rhabdomyosarcoma. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Childhood Rhabdomyosarcoma sessions?
Cancer researchers and clinicians, educators and students with an interest in Childhood Rhabdomyosarcoma are all welcome — whether presenting or attending.
Can I present my research in the Childhood Rhabdomyosarcoma track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Childhood Rhabdomyosarcoma sessions?
Yes. CIOC 2027 is a hybrid conference — attend the Childhood Rhabdomyosarcoma track in person in Singapore or join live online, with on-demand access afterward.
Join the CIOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.